Standing Order
Pfizer Inc.

Dashboard

Pfizer Inc.

PFENYSE

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$161B
Price$28.1852w $23.29 – $29.02
Conviction3/ 5
Revenue (TTM)$63.7B
Revenue growth YoY-0.2%
P/E (trailing)37.1
Gross margin71.3%
Operating margin25.1%
Net margin6.8%
52w price change+17.6%
Next earningsNov 3, 2026

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Sep 16
    Ownership changeSEC

    SEC Form 4 insider ownership change filing.

  • Sep 1
    Ownership changeSEC

    SEC Form 4 insider ownership report filed.

  • Aug 27
    DealFederal award

    Pfizer awarded $11.11B DoD contract for COVID-19 vaccine production (award W15QKN21C0012).

    $11.1B
  • Aug 17
    Ownership changeSEC

    SEC Form 4 filing reporting change in beneficial ownership.

  • Aug 12
    Ownership changeSEC

    SEC Form 4 insider transaction filing reporting change in beneficial ownership.

  • Aug 6
    Ownership changeSEC

    Pfizer insider filed SEC Form 4 reporting transaction.

  • Aug 5
    Ownership changeSEC

    SEC Form 4 filing reporting change in beneficial ownership by insider at Pfizer.

  • Aug 5
    Ownership changeSEC

    SEC Form 4 insider beneficial ownership change filing.

  • Aug 4
    Financial resultsSEC

    Pfizer files 8-K (items 2.02, 9.01) disclosing results of operations and financial condition.

  • Aug 3
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jul 16
    Ownership changeSEC

    Form 4 insider ownership change report filed 2026-07-16.

  • Jul 13
    Ownership changeSEC

    Form 4 insider transaction report filed.

  • Jul 1
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jun 30
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jun 30
    Ownership changeSEC

    SEC Form 4 insider beneficial ownership change filing.

  • Jun 30
    Ownership changeSEC

    SEC Form 4 insider transaction filing dated 2026-06-30.

  • Jun 30
    Ownership changeSEC

    Form 4 filing reporting change in beneficial ownership.

  • Jun 30
    Ownership changeSEC

    SEC Form 4 insider beneficial ownership change filing.

  • Jun 30
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jun 18
    OtherSEC

    Pfizer files 8-K under item 7.01 (Regulation FD disclosure).

Not financial advice — research and opinion only. Disclosures